-
Emergency contraception (EC), once considered the nations best-kept secret, may be a secret no longer when a major pharmaceutical company takes over a popular dedicated EC product.
-
A young woman recently died after undergoing a medical abortion. Patients are anxious and asking questions. How do you respond?
-
What is the accepted practice for checking blood pressure following initial starts on oral contraceptives?
-
Just as you have integrated new methods such as the transdermal contraceptive and the contraceptive vaginal ring into your practice, be prepared to see more options added to the contraceptive mix.
-
Attend the first International Conference on Women and Infectious Diseases, scheduled for Feb. 27-28, 2004, in Atlanta.
-
Twelve cycles of single-agent paclitaxel administered to women with advanced ovarian cancer who attain a clinically defined complete response to initial platinum/paclitaxel-based chemotherapy significantly prolongs the duration of progression-free survival.
-
Malignant pleural mesothelioma (MPM) is an uncommon tumor that carries a dismal prognosis. Its incidence is rising and is expected to continue climbing as more patients reach the end of the 35-40-year lag period between asbestos exposure and tumor development.
-
The prevention of acute chemotherapy-induced nausea and vomiting (CINV) has improved dramatically in the past decade.
-
A generic form of paroxetine (PaxilGlaxoSmithKline) will soon be on the market. The drug marks the second SSRI antidepressant to go generic after fluoxetine (Prozac) last year.
-